Understand how mesenchymal stem cells from Wharton’s Jelly offer a regenerative option for heart failure, delivering powerful anti-inflammatory signals and growth factors that help reduce scarring and stimulate tissue repair in damaged hearts.
Discover the non-surgical process of delivering stem cells directly to the heart via catheterization, allowing precise placement into coronary arteries or even heart muscle without invasive procedures or long recovery times.
Learn who makes an ideal candidate for this treatment and how it fits within a lifestyle-focused, integrative care plan, with real-world results showing improved ejection fractions, reduced symptoms, and long-term stability—all outside the U.S. due to current FDA regulations.
Joel Kahn, MD, FACC of Detroit, Michigan, is a practicing cardiologist, and a Clinical Professor of Medicine at Wayne State University School of Medicine. He graduated Summa Cum Laude from the University of Michigan Medical...
Dr. Leonardo Gonzalez is the founder and Medical Director of the International Stem Cell Institute (ISCI), a premier clinic in Bogota, Colombia, that specializes in stem cell therapies and cutting-edge medical treatments. A visionary in...